Zaman Fahim, Pervez Aslam, Atray Naveen K, Murphy Sara, Work Jack, Abreo Kenneth D
Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA.
Semin Dial. 2005 May-Jun;18(3):247-51. doi: 10.1111/j.1525-139X.2005.18321.x.
In the early 1950s and 1960s, peritoneal dialysis (PD) was used primarily to treat patients with acute renal failure. Continuous ambulatory peritoneal dialysis (CAPD) was introduced in 1976 and continues to gain popularity as an effective method of renal replacement therapy for patients with end-stage renal disease (ESRD). The PD catheter is inserted into the abdominal cavity either by a surgeon, interventional radiologist, or nephrologist. We have adopted a percutaneous approach with fluoroscopic guidance for PD catheter insertion that is easy, safe, and provides good patency and infection rate results. In this article we describe the technique and our results. From August 2000 to May 2003, 34 PD catheters out of 36 were successfully inserted using the percutaneous fluoroscopic technique in selected patients referred from the nephrology clinic. All the PD catheters were placed in our Interventional Nephrology Vascular Suite by nephrologists.
在20世纪50年代初和60年代,腹膜透析(PD)主要用于治疗急性肾衰竭患者。持续非卧床腹膜透析(CAPD)于1976年被引入,并作为终末期肾病(ESRD)患者有效的肾脏替代治疗方法持续受到欢迎。PD导管可由外科医生、介入放射科医生或肾病科医生插入腹腔。我们采用了在透视引导下经皮插入PD导管的方法,该方法简便、安全,且通畅率和感染率效果良好。在本文中,我们描述了该技术及我们的结果。从2000年8月至2003年5月,在从肾病科诊所转诊的选定患者中,36根PD导管中有34根使用经皮透视技术成功插入。所有PD导管均由肾病科医生放置在我们的介入肾脏病血管套房中。